Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways [Erratum]
Ren H, Li Y, Chen Y, Wang L. Drug Des Devel Ther. 2019; 13:285–290.On page 289, Figure 4 and Notes should read as follows:Figure 4 Endostatin inhibits the expression of α-SMA, RhoA, and ROCK1 at mRNA level.Notes: Transcript levels of α-SMA, RhoA, and ROCK1 were...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-01-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | https://www.dovepress.com/erratum-endostatin-attenuates-pdgf-bb--or-tgf-beta1-induced-hscs-peer-reviewed-article-DDDT |